Yield10 Bioscience Announces Third Quarter 2021 Financial Results

Go back to Yield10 Bioscience Announces Third Quarter 2021 Financial Results

Yield10 Bioscience, Inc. (YTEN) Tops Q3 EPS by 16c

November 10, 2021 4:23 PM EST

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.49), $0.16 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $92 thousand versus the consensus estimate of $210 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

... More